Vinva Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Sell |
10,345
-2,792
| -21% | -$1.23M | 0.12% | 173 |
|
|
2025
Q1 | $6.47M | Buy |
13,137
+9,625
| +274% | +$4.74M | 0.26% | 101 |
|
|
2024
Q4 | $1.4M | Buy |
3,512
+1,069
| +44% | +$427K | 0.05% | 260 |
|
|
2024
Q3 | $1.13M | Sell |
2,443
-6,784
| -74% | -$3.14M | 0.05% | 280 |
|
|
2024
Q2 | $4.36M | Sell |
9,227
-479
| -5% | -$226K | 0.22% | 113 |
|
|
2024
Q1 | $4.06M | Buy |
9,706
+703
| +8% | +$294K | 0.23% | 113 |
|
|
2023
Q4 | $3.68M | Buy |
9,003
+1,006
| +13% | +$412K | 0.25% | 101 |
|
|
2023
Q3 | $2.82M | Buy |
7,997
+121
| +2% | +$42.7K | 0.26% | 89 |
|
|
2023
Q2 | $2.74M | Sell |
7,876
-881
| -10% | -$307K | 0.24% | 106 |
|
|
2023
Q1 | $2.73M | Buy |
+8,757
| New | +$2.73M | 0.23% | 116 |
|